Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2601 to 2650 of 16578 in total
Value Type: Ranked
Filtered: 1

\def\wcA{0.11111111111111\textwidth}
\def\wcB{0.11111111111111\textwidth}
\def\wcC{0.11111111111111\textwidth}
\def\wcD{0.11111111111111\textwidth}
\def\wcE{0.11111111111111\textwidth}
\def\wcF{0.11111111111111\textwidth}
\def\wcG{0.11111111111111\textwidth}
\def\wcH{0.11111111111111\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
651\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
large proline-rich protein bat3 (hla-b-associated transcript 3) (g3). [source:swissprot;acc:p46379]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
207.662\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
201.876\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02866\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
BAIAP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bai1-associated protein 3; bai-associated protein 3. [source:refseq;acc:nm\_003933]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
233.725\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
220.751\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05877\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q99928]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.117\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin alpha-6 precursor (vla-6) (cd49f). [source:swissprot;acc:p23229]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.321\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.601\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.72\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
652\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tgf beta-inducible nuclear protein 1; hairy cell leukemia protein 1. [source:refseq;acc:nm\_014886]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
248.994\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
235.255\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.0584\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
FOXG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
forkhead box protein g1c (forkhead-related protein fkhl3) (hfk3) (fragment). [source:swissprot;acc:q14488]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.117\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGA7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin alpha-7 precursor. [source:swissprot;acc:q13683]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.601\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.719\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZNF593\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein t86. [source:swissprot;acc:o00488]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
205.897\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.163\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02865\vspace{3pt}}\\\cline{1-3}\cline{5-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
653\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
dok-like protein. [source:refseq;acc:nm\_024872]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\cline{3-4}\cline{6-8}
&&\parbox{\wcC}{\vspace{3pt}\noindent
interleukin-1 receptor-associated kinase 4; interleukin-1 receptor associated kinase 4. [source:refseq;acc:nm\_016123]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.117\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
DHODH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dihydroorotate dehydrogenase, mitochondrial precursor (ec 1.3.3.1) (dihydroorotate oxidase) (dhodehase) (fragment). [source:swissprot;acc:q02127]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.975\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.304\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.0286\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGA3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin alpha-3 precursor (galactoprotein b3) (gapb3) (vla-3 alpha chain) (cd49c). [source:swissprot;acc:p26006]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
206.32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.601\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.719\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
654\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DOK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
docking protein 2 (p56(dok-2)) (downstream of tyrosine kinase 2). [source:swissprot;acc:o60496]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GULP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ptb domain adaptor protein ced-6; engulfment adapter protein. [source:refseq;acc:nm\_016315]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.911\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.193\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.718\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
JMJD6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphatidylserine receptor; phosphatidylserine receptor beta. [source:refseq;acc:nm\_015167]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.117\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZEB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger homeobox protein 1b (smad interacting protein 1) (smadip1) (hrihfb2411). [source:swissprot;acc:o60315]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.995\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.27\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02859\vspace{3pt}}\\\cline{1-3}\cline{5-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
655\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DOK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
docking protein 1 (p62(dok)) (downstream of tyrosine kinase 1) (pp62). [source:swissprot;acc:q99704]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q8n1c3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
HEMK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hemk protein homolog (ec 2.1.1.-) (m.hsahemkp). [source:swissprot;acc:q9y5r4]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.104\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
197.399\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.705\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZEB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor 8 (nil-2-a zinc finger protein) (negative regulator of il2). [source:swissprot;acc:p37275]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
205.995\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.27\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02859\vspace{3pt}}\\\cline{1-3}\cline{5-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
656\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
FRK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p47869]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin beta-1 precursor (fibronectin receptor beta subunit) (cd29 antigen) (integrin vla-4 beta subunit). [source:swissprot;acc:p05556]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.277\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.582\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.695\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin beta-2 precursor (cell surface adhesion glycoproteins lfa- 1/cr3/p150,95 beta-subunit) (cd18) (complement receptor c3 beta- subunit). [source:swissprot;acc:p05107]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
206.339\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.608\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02857\vspace{3pt}}\\\cline{1-4}\cline{6-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
657\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CCDC53\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein ad-016 (protein cgi-116) (x0009). [source:swissprot;acc:q9y3c0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
207.03\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
201.339\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.691\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-6 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q16445]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGB7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin beta-7 precursor. [source:swissprot;acc:p26010]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.341\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.609\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02857\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
SYN3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
synapsin iii. [source:swissprot;acc:o14994]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcH}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}}\\\cline{1-3}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
658\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&&&&\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ARFGEF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
brefeldin a-inhibited guanine nucleotide-exchange protein 1 (brefeldin a-inhibited gep 1) (p200 arf-gep1) (p200 arf guanine nucleotide exchange factor). [source:swissprot;acc:q9y6d6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.293\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
197.621\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.672\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p18507]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGB3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin beta-3 precursor (platelet membrane glycoprotein iiia) (gpiiia) (cd61 antigen). [source:swissprot;acc:p05106]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.342\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.61\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02857\vspace{3pt}}\\\cline{1-4}\cline{6-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
659\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DHODH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dihydroorotate dehydrogenase, mitochondrial precursor (ec 1.3.3.1) (dihydroorotate oxidase) (dhodehase) (fragment). [source:swissprot;acc:q02127]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
203.975\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.304\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.671\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRA4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-4 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p48169]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
HEY1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 1 (hairy and enhancer of split related-1) (hesr-1) (cardiovascular helix-loop-helix factor 2) (hes-related repressor protein 2 herp2). [source:swissprot;acc:q9y5j3]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
TP53I3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tumor protein p53 inducible protein 3; quinone oxidoreductase homolog; p53-induced gene 3 protein. [source:refseq;acc:nm\_004881]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
175.504\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
170.633\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02855\vspace{3pt}}\\\cline{1-3}\cline{5-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
660\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ABLIM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
actin binding lim protein 2. [source:refseq;acc:nm\_032432]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor epsilon subunit precursor (gaba(a) receptor). [source:swissprot;acc:p78334]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGA7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin alpha-7 precursor. [source:swissprot;acc:q13683]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.601\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02851\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
SKP1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
s-phase kinase-associated protein 1a (cyclin a/cdk2-associated protein p19) (p19a) (p19skp1) (rna polymerase ii elongation factor-like protein) (organ of corti protein 2) (ocp-ii protein) (ocp-2) (transcription elongation factor b) (siii). [source:swissprot;acc:p34991]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
204.882\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
199.214\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.668\vspace{3pt}}\\\cline{1-3}\cline{6-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
661\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARFGEF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
brefeldin a-inhibited guanine nucleotide-exchange protein 2 (brefeldin a-inhibited gep 2). [source:swissprot;acc:q9y6d5]\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
203.283\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
197.617\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.666\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p14867]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
HEYL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif-like. [source:refseq;acc:nm\_014571]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
SOS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
son of sevenless protein homolog 1 (sos-1). [source:swissprot;acc:q07889]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.62\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
195.059\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02851\vspace{3pt}}\\\cline{1-4}\cline{6-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
662\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sh2 domain binding protein 1; tpr-containing, sh2-binding phosphoprotein. [source:refseq;acc:nm\_014633]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
206.115\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.462\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.653\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRA3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p34903]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin alpha-6 precursor (vla-6) (cd49f). [source:swissprot;acc:p23229]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.321\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.601\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02851\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
SYN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
synapsin ii. [source:swissprot;acc:q92777]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
663\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tgf beta-inducible nuclear protein 1; hairy cell leukemia protein 1. [source:refseq;acc:nm\_014886]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.551\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.901\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.65\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ITGA3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin alpha-3 precursor (galactoprotein b3) (gapb3) (vla-3 alpha chain) (cd49c). [source:swissprot;acc:p26006]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
206.32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.601\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02851\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/